SPP1 and Duchenne muscular dystrophy: These differential effects are likely to be important in determining the outcome of various conditions involving muscle inflammation, but most particularly Duchenne muscular dystrophy, for which the osteopontin gene is a strong genetic modifier of disease severity [13].